Nobivac Feline 1-HCPCH

Description

NOBIVAC® Feline 1-HCPCh has been shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses, as well as feline Chlamydophila*.

Benefits

Subcutaneous or intramuscular injection
Initial 1 mL dose administered at 9 weeks of age or older
Second 1 mL dose administered 3 to 4 weeks later
Contact your veterinarian or manufacturer for more information on revaccination frequency.
Available in a 25 x 1 mL dose presentation

Dosage and Administration

Transfer contents of the diluent vial to the Nobivac^®: Feline 1-HCPCh vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.

Two doses are required for primary immunization.

• Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older.
• Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination.

WARNINGS:

• Contains gentamicin as a preservative.
• Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.
• Do not vaccinate pregnant cats.
• The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

Nobivac Feline 1-HCPCH is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.

Click here for our Vaccine Shipping Schedule.